← Open Payments lookup

APRIL MARTIN: Open Payments

NPI 1447028741 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$757 in 29 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $236 · 2025 $757

Food & beverage: $757
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc6$226
Axsome Therapeutics, Inc.4$96
Stryker Corporation1$85
Otsuka America Pharmaceutical, Inc.3$77
Vanda Pharmaceuticals Inc.4$72
ABBVIE INC.3$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$47
Supernus Pharmaceuticals, Inc.1$22
Lundbeck LLC1$21
E.R. Squibb & Sons, L.L.C.1$20

Products named: SPRAVATO, REXULTI, Auvelity, NEPTUNE, FANAPT, VRAYLAR, INVEGA SUSTENNA, CAPLYTA.

Industry payments across MS — which companies pay providers there.